跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VIZOMET OINTMENT 0.1% W/W - HSA Drug Approval Details
Approvals
/
HSA
/
VIZOMET OINTMENT 0.1% W/W
Approved
THERAPEUTIC
VIZOMET OINTMENT 0.1% W/W
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
🇸🇬 Health Sciences Authority
Approval Date
Feb 1, 2019
Approval ID
ea1c48a3b30e22a1
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Type
Therapeutic
Approval Details
Approval Id
ea1c48a3b30e22a1
Drug Name
VIZOMET OINTMENT 0.1% W/W
Product Name
VIZOMET OINTMENT 0.1% W/W
Approval Number
SIN15619P
Approval Date
2019-02-01
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
OINTMENT
Route Of Administration
TOPICAL
Atc Code
D07AC13
Atc Item Name
mometasone
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
MOMETASONE FUROATE
0.1% W/W
MOMETASONE FUROATE
0.1% W/W
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 1, 2019
Approval ID
ea1c48a3b30e22a1
Type
Therapeutic
Back to HSA Approvals